Loading...

Sight Sciences, Inc.

SGHTNASDAQ
Healthcare
Medical - Devices
$3.49
$-0.07(-1.97%)

Sight Sciences, Inc. (SGHT) Company Profile & Overview

Explore Sight Sciences, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Sight Sciences, Inc. (SGHT) Company Profile & Overview

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

SectorHealthcare
IndustryMedical - Devices
CEOPaul Badawi

Contact Information

877 266 1144
4040 Campbell Avenue, Menlo Park, CA, 94025

Company Facts

216 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;